decisionhealth Newsletters, Part B News - 2004 Issue 4 (April)
Criteria Released for Replacement Drug Demo
Subscribe or sign in to view the full article.
Article Overview
The article covers CMS guidance for a Medicare demonstration project involving replacement drugs, including broad eligibility criteria for drugs, patient enrollment considerations, and spending limits for different categories of covered drugs. It is relevant to coders, billing staff, compliance teams, and health policy readers following Medicare Part B and demonstration project implementation.
Why This Topic Matters
The piece explains how CMS is framing participation in a new Medicare demonstration project and what categories of drugs may be considered, which can affect coverage, reimbursement planning, and administrative preparation.
What You Will Learn
- The general purpose of the Medicare replacement drug demonstration project
- The types of broad criteria CMS says it will use to evaluate drug eligibility
- How patient enrollment for the demonstration may be approached
- The spending categories CMS has set for the demo
- What CMS is doing to gather stakeholder input on the project
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Compliance professionals
- Healthcare administrators
- Health policy readers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com